Our NIDDK-funded Center for Iron and Hematology Disorders has awarded three pilot research grants for the 2016/2017 fiscal year. Six proposals were considered for funding and the three successful applicants include the following:... Read MoreInternal Medicine
Division of Hematology & Hematologic Malignancies
The scientific focus of our division is the study of blood and bone marrow in health and disease. Our physicians treat patients with blood cancer, such as leukemias and lymphomas; clotting disorders, such as hemophilia; and diseases of iron metabolism, such as hemochromatosis. Starting with Maxwell Wintrobe, one of the founding fathers of Hematology and the University of Utah Medical School, our division can look back at a long-standing tradition of excellence in research, clinical care and teaching.
Last year researchers from our division garnered more than $7,000,000 in grant income, presented their data at major conferences, and published their results in prime international journals. This would not be possible without the University of Utah’s outstanding collaborative environment and its strong scientific foundation.
We are pleased to welcome Dr. Vedran Radojcic to the faculty in the Division of Hematology and Hematologic Malignancies. Dr. Radojcic was born and raised in Croatia where he completed his medical training. After completing internship in the Bone Marrow Transplantation Unit and a research fellowship at University of Zagreb, he joined the Johns Hopkins University School of Medicine as a postdoctoral fellow, focusing on immunology of blood and marrow transplantation. He subsequently relocated to the University of Michigan where he completed internship and residency in Internal Medicine as the "Most Outstanding House Officer". Upon completion of his residency, he accepted a fellowship in Hematology/Oncology at the University of Michigan and was awarded the Mark Roth Memorial Award in the Division of Hematology/Oncology. His research as a fellow was sponsored through the T32 training grant, American Society of Hematology Research Training award for Fellows, and Robert A. Good New Investigator Award by the American Society of Blood and Marrow Transplantation. His research is focused on immunobiology of graft-versus-host disease and was instrumental in identifying Notch signaling in T cells as a therapeutic target for preventingchronic graft-versus-host disease. Dr. Radojcic will join the Bone Marrow Transplantation program at the Huntsman Cancer Institute and establish a laboratory-focused research program in transplant immunology. We welcome Dr. Radojcic to our faculty.... Read MoreInternal Medicine
We are pleased to welcome Dr. Douglas Sborov to the faculty in the Division of Hematology and Hematologic Malignancies. Dr. Sborov was born and raised in Minneapolis, MN, graduated from the University of Wisconsin-Madison with his Bachelors of Science, and completed his medical training at The American University of the Caribbean School of Medicine. Following medical school, he completed his Internal Medicine Residency at the University of Utah, and later his Hematology, Oncology, and Bone Marrow Transplant Fellowship at The Ohio State University. During this time, he obtained his Masters in Medical Science with a concentration in tumor immunology, and completed the National Institutes of Health (NIH) funded T32 training grant with a focus in clinical research and trial development. Over the course of his training, Dr. Sborov developed a passionate interest in the development of novel therapeutics for the treatment of patients with multiple myeloma, as well treating patients undergoing bone marrow transplantation. Dr. Sborov will join the myeloma program at the Huntsman Cancer Institute. We welcome Dr. Sborov to our faculty.... Read MoreInternal Medicine